Lupin launched Clobetasol Propionate in US market

Posted on:13 Oct 2018 11:11:53
Lupin launched Clobetasol Propionate in US market
13 October 2018 Current Affairs: Lupin, Drug firm major, has launched generic Clobetasol Propionate ointment in the U.S. market. This is used to treat inflammation and itching caused by a number of skin conditions. It had earlier received approval for the product from the United States Food and Drug Administration (USFDA), Lupin said in a statement. The company has launched Clobetasol Propionate ointment USP in the strength of 0.05%.
Lupin, Drug firm major, has launched generic Clobetasol Propionate ointment in the U.S. market. This is used to treat inflammation and itching caused by a number of skin conditions. It had earlier received approval for the product from the United States Food and Drug Administration (USFDA), Lupin said in a statement. The company has launched Clobetasol Propionate ointment USP in the strength of 0.05%.

Monthly Current Affairs

Fresherslive telegram Group

Current Affairs Section

Daily Current Affairs Quiz

Subscribe to Current Affairs

Enter your email to get daily current affairs

Current Affairs Weekly PDF

Current Affairs Monthly PDF

Current Affairs Quiz

Current Affairs Monthly PDF Hindi

Currentt Affairs 2019 January

19 JANUARY
NEWS
18 JANUARY
NEWS
17 JANUARY
NEWS

Currentt Affairs 2018 December

31 DECEMBER
NEWS
30 DECEMBER
NEWS
29 DECEMBER
NEWS
28 DECEMBER
NEWS

Currentt Affairs 2018 November

30 NOVEMBER
NEWS
29 NOVEMBER
NEWS
28 NOVEMBER
NEWS
27 NOVEMBER
NEWS